ArticlePharmacology research & perspectives2025
Assessments of CYP-Inhibition-Based Drug-Drug Interactions Between Tofacitinib and Lipid-Lowering Agents in Rats Both In Vitro and In Vivo.
Hang Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.